Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-175076
Filing Date
2024-07-03
Accepted
2024-07-03 16:34:45
Documents
8
Effectiveness Date
2024-07-03

Document Format Files

Seq Description Document Type Size
1 S-8 d792535ds8.htm S-8 55964
2 EX-5.1 d792535dex51.htm EX-5.1 58889
3 EX-23.2 d792535dex232.htm EX-23.2 1456
4 EX-99.1 d792535dex991.htm EX-99.1 162785
5 EX-99.2 d792535dex992.htm EX-99.2 149661
6 EX-FILING FEES d792535dexfilingfees.htm EX-FILING FEES 28137
7 GRAPHIC g792535dsp01.jpg GRAPHIC 2353
8 GRAPHIC g792535g69p07.jpg GRAPHIC 2387
  Complete submission text file 0001193125-24-175076.txt   464821
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280689 | Film No.: 241100563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)